Published in Neuropharmacology on April 01, 2002
Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res (2009) 2.01
A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells. PLoS One (2010) 1.45
Eosinophilic myenteric ganglionitis is associated with functional intestinal obstruction. Gut (2003) 1.27
Teriflunomide and its mechanism of action in multiple sclerosis. Drugs (2014) 1.08
Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model. Clin Diagn Lab Immunol (2004) 1.08
The role of cytokines in Guillain-Barré syndrome. J Neurol (2010) 1.00
Molecular pharmacodynamics of new oral drugs used in the treatment of multiple sclerosis. Drug Des Devel Ther (2014) 0.85
Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A (2016) 0.83
Risks vs benefits of glatiramer acetate: a changing perspective as new therapies emerge for multiple sclerosis. Ther Clin Risk Manag (2010) 0.83
Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study. Immun Inflamm Dis (2015) 0.82
Laquinimod, an up-and-coming immunomodulatory agent for treatment of multiple sclerosis. Exp Neurol (2014) 0.81
What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis? Int J Mol Sci (2012) 0.81
Promising treatments of tomorrow for multiple sclerosis. Ann Indian Acad Neurol (2009) 0.79
Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells. J Neurochem (2016) 0.77
Efficacy and safety of laquinimod in multiple sclerosis: current status. Ther Adv Neurol Disord (2013) 0.77
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease. Sci Rep (2016) 0.75
Update on immunopathogenesis and immunotherapy in multiple sclerosis. Immunotargets Ther (2013) 0.75
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System. Int J Mol Sci (2015) 0.75
SPIDER and WEB: processing and visualization of images in 3D electron microscopy and related fields. J Struct Biol (1996) 22.89
Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09
Lipid rafts reconstituted in model membranes. Biophys J (2001) 9.19
Influence of social network on occurrence of dementia: a community-based longitudinal study. Lancet (2000) 7.31
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost (2001) 6.16
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78
Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A (1998) 4.72
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid. Nat Genet (1992) 4.31
Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res (1995) 4.11
DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation. Nature (2000) 4.10
Response to RAG-mediated VDJ cleavage by NBS1 and gamma-H2AX. Science (2000) 3.95
Two autosomal dominant neuropathies result from reciprocal DNA duplication/deletion of a region on chromosome 17. Hum Mol Genet (1994) 3.67
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J Exp Med (2001) 3.62
Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol (1999) 3.62
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56
A model of protein synthesis based on cryo-electron microscopy of the E. coli ribosome. Nature (1995) 3.56
Effect of mutations in genes affecting homologous recombination on restriction enzyme-mediated and illegitimate recombination in Saccharomyces cerevisiae. Mol Cell Biol (1994) 3.41
Myocardial ischemia and reperfusion: a murine model. Am J Physiol (1995) 3.38
Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet (1996) 3.26
Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol (2001) 3.19
Partitioning of Thy-1, GM1, and cross-linked phospholipid analogs into lipid rafts reconstituted in supported model membrane monolayers. Proc Natl Acad Sci U S A (2001) 3.12
A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J Neurosci (1999) 2.92
Rocuronium (Org 9426) for caesarean section. Br J Anaesth (1994) 2.86
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet (1997) 2.77
Therapeutic immunisation with recombinant gp160 in HIV-1 infection: a randomised double-blind placebo-controlled trial. Nordic VAC-04 Study Group. Lancet (1999) 2.74
Predictors of progression from mild cognitive impairment to Alzheimer disease. Neurology (2007) 2.72
Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci (1997) 2.59
Sequestration and inhibition of Daxx-mediated transcriptional repression by PML. Mol Cell Biol (2000) 2.59
Two-photon fluorescence microscopy of laurdan generalized polarization domains in model and natural membranes. Biophys J (1997) 2.56
Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation (2001) 2.56
Activation and cleavage of caspase-3 in apoptosis induced by experimental cerebral ischemia. J Neurosci (1998) 2.55
An alternative-exon database and its statistical analysis. DNA Cell Biol (2000) 2.51
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet (2000) 2.49
Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc Natl Acad Sci U S A (1996) 2.48
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology (2012) 2.45
Three ARS elements contribute to the ura4 replication origin region in the fission yeast, Schizosaccharomyces pombe. EMBO J (1994) 2.38
The course of cognitive impairment in preclinical Alzheimer disease: three- and 6-year follow-up of a population-based sample. Arch Neurol (2000) 2.37
Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37
A common-lines based method for determining orientations for N > 3 particle projections simultaneously. Ultramicroscopy (1996) 2.32
The appropriateness of drug use in an older nondemented and demented population. J Am Geriatr Soc (2001) 2.30
Education and dementia: what lies behind the association? Neurology (2007) 2.26
The no-scalpel vasectomy. J Urol (1991) 2.24
Infection and atherosclerosis: emerging mechanistic paradigms. Circulation (1999) 2.23
Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ (1996) 2.20
[Co-morbidity in acutely hospitalised older patients as a risk factor for death in hospital or within 3 months after discharge]. Ned Tijdschr Geneeskd (2007) 2.17
PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. J Control Release (2001) 2.15
Cytomegalovirus DNA detection in sera from patients with active cytomegalovirus infections. J Clin Microbiol (1992) 2.14
Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg (2004) 2.14
Very old women at highest risk of dementia and Alzheimer's disease: incidence data from the Kungsholmen Project, Stockholm. Neurology (1997) 2.14
Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology (2004) 2.10
Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost (2004) 2.09
Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol (1999) 2.08
An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Disord (2006) 2.08
Regulation of nitrogen fixation in Klebsiella pneumoniae: isolation and characterization of strains with nif-lac fusions. J Bacteriol (1981) 2.07
Highly attenuated modified vaccinia virus Ankara replicates in baby hamster kidney cells, a potential host for virus propagation, but not in various human transformed and primary cells. J Gen Virol (1998) 2.06
SAGE transcript profiles for p53-dependent growth regulation. Oncogene (1997) 2.06
Prevalence of Alzheimer's disease and other dementias in an elderly urban population: relationship with age, sex, and education. Neurology (1991) 2.05
Simultaneous liquid chromatographic determination of seventeen of the major monoamine neurotransmitters, precursors and metabolites. II. Assessment of human brain and cerebrospinal fluid concentrations. J Chromatogr (1987) 2.04
Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology (2001) 2.04
Scanning electron microscopic study of virulent and avirulent colonies of Neisseria gonorrhoeae. Infect Immun (1975) 2.03
14-3-3 proteins; bringing new definitions to scaffolding. Oncogene (2001) 2.03
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost (2015) 2.02
Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol (1997) 1.99
Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J Virol (1987) 1.99
Acute confusional states in elderly patients treated for femoral neck fracture. J Am Geriatr Soc (1988) 1.95
Relative abundance of Alzheimer A beta amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci U S A (1994) 1.91
Defective brain microtubule assembly in Alzheimer's disease. Lancet (1986) 1.89
Diabetes, Alzheimer disease, and vascular dementia: a population-based neuropathologic study. Neurology (2010) 1.88
Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein. Proc Natl Acad Sci U S A (1996) 1.86
Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study. J Neurol Neurosurg Psychiatry (1998) 1.83
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study. Neurology (2007) 1.81
Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet (1998) 1.80
An interchangeable ELISA for cytomegalovirus antigen and antibody. J Virol Methods (1981) 1.80
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease. Neurology (1999) 1.78
Virus-specific antibody activity of different subclasses of immunoglobulins G and A in cytomegalovirus infections. Infect Immun (1983) 1.78
Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol (1996) 1.77
Identification of human neutralization-inducing regions of the human immunodeficiency virus type 1 envelope glycoproteins. Proc Natl Acad Sci U S A (1992) 1.77
Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014. J Intern Med (2014) 1.75
Size dependence of Young's modulus in ZnO nanowires. Phys Rev Lett (2006) 1.74
Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins. Immunol Lett (1991) 1.73
Monoclonal antibody against vascular cell adhesion molecule-1 inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol (2000) 1.73
Cerebellar leukoencephalopathy: most likely histiocytosis-related. Neurology (2008) 1.73
Changes in the brain catecholamines in patients with dementia of Alzheimer type. Br J Psychiatry (1979) 1.71
Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71
nompA encodes a PNS-specific, ZP domain protein required to connect mechanosensory dendrites to sensory structures. Neuron (2001) 1.71
Neutralizing cross-reactive and non-neutralizing monoclonal antibodies to HIV-1 gp120. AIDS (1990) 1.71
Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc Natl Acad Sci U S A (2000) 1.70
Distribution of different fiber types in human skeletal muscles: effects of aging studied in whole muscle cross sections. Muscle Nerve (1983) 1.70
Rhinovirus induces MUC5AC in a human infection model and in vitro via NF-κB and EGFR pathways. Eur Respir J (2010) 1.70
Genes that are uniquely stress regulated in salt overly sensitive (sos) mutants. Plant Physiol (2001) 1.69
Epstein-Barr virus DNA in cerebrospinal fluid from patients with AIDS-related primary lymphoma of the central nervous system. Lancet (1993) 1.68
The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology (1999) 1.67
Homocysteine and holotranscobalamin and the risk of Alzheimer disease: a longitudinal study. Neurology (2010) 1.67
Neuropathologic findings and neurologic symptoms in twenty-three children with hemophagocytic lymphohistiocytosis. J Pediatr (1997) 1.66